Taejoon’s Tech Wonders Recognized at RSNA Conference

Published: 2004-12-13 06:54:00

Updated: 2004-12-13 06:54:00

At the 90th annual Radiological Society of North America (RSNA) Conference, held from November 28th to December 3rd, Taejoon Pharmaceutical achieved $0.85 million USD worth of export agreements and over $5.5 million USD of potential exporting engagements, from discussions with 48 buyers represent...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK